Cytori
Therapeutics Inc. (NASDAQ: CYTX) will present and provide a
corporate update from the 25th
Annual Roth Conference on Monday, March 18 at 4:30 PM PT.
The presentation will be webcast and may be accessed under “Webcasts”
under Cytori’s Investor Relations section of the website. The webcast
can be viewed live and will be available for replay after the
presentation on the Company's website.
About Cytori
Cytori Therapeutics, Inc. is developing cell therapies based on
autologous adipose-derived regenerative cells (ADRCs) to treat
cardiovascular disease and repair soft tissue defects. Our scientific
data suggest ADRCs improve blood flow, moderate the inflammatory
response and keep tissue at risk of dying alive. As a result, we believe
these cells can be applied across multiple “ischemic” conditions. These
therapies are made available to the physician and patient at the
point-of-care by Cytori’s proprietary technologies and products,
including the Celution® system product family. www.cytori.com
Stockhouse.com: Taking
it to the street
